Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report By Disease Type (Neurological, Endocrine & Metabolism Diseases), By Technology (NGS, FISH), By Specialty, By End Use, And Segment Forecasts, 2020 - 2027

Rare Disease Genetic Testing Market Growth Market Growth & Trends Trends

The global rare disease genetic testing market size is expected to reach USD 1.8 billion by 2027 expanding at a CAGR of 10.8% over the forecast period, according to a new report by Grand View Research, Inc. Conventional test methods provide delayed diagnosis. Moreover, patients need to visit physicians to correctly identify a rare condition, leading to an increased healthcare spending. This has spurred the adoption of genetic test methods for accurate and timely identification of rare conditions.

Ongoing scientific advances in this area have created new opportunities for the companies to develop solutions that can impact the management of the rare condition. Collaborations are being undertaken not only across diverse medical and scientific domains but also with various stakeholder groups, such as researchers, patients, and regulators, for new test development, thereby driving the market.

For instance, in October 2018, PerkinElmer Genomics signed an agreement with Sanofi Genzyme to introduce a free genetic testing program called the Lantern Project. The initiative was designed for patients who have or are suspected of having, certain types of lysosomal storage disorders, including Gaucher disease.

Rare Disease Genetic Testing Market Report Highlights

  • Neurological disorders accounted for the major revenue share in 2019 owing to availability of a substantial number of test offerings by various companies, such as Invitae and Centogene
  • Furthermore, the National Institute of Neurological Disorders and Stroke supports research studies for a wide range of diseases, thereby positively impacting the segment growth
  • Availability and adoption of NGS-based gene panels for cancer, neurologic disease, CVDs, and other rare disease testing has driven the NGS segment
  • NGS has enabled rapid and cost-effective genetic testing by helping in determining the relevance of de novo and mosaic mutations
  • It has also helped in detecting the wide phenotypic spectrum of genes, digenic inheritance, and presence of more than one rare condition in the same individual
  • Thus, a significant decline in the cost of NGS has driven its adoption for molecular testing, contributing to the large share of molecular genetic tests
  • Laboratories are engaged in conducting a substantial number of genetic tests. This includes labs that are accredited with CLIA for clinical cytogenetics, pathology, and chemistry, among other specialties
  • Furthermore, regulatory bodies play a major role in the growth of this segment, as they help laboratories conduct effective and safe genetic testing, leading to their dominance as end-user of the market
  • North America led the global market in 2019 owing to the presence of key research and diagnostic laboratories in U.S.


Please note:This report is an On-Demand title and will be delivered within 10-12 business days post confirmation

Chapter 1 Executive Summary
1.1 Market Summary
Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Information or Data Analysis
2.3 Market Model
2.3.1 Market study, by disease
2.3.2 Market study, by technology
2.3.3 Market study, by specialty
2.3.4 Market study, by end use
2.3.5 Regional analysis
2.3.6 Company Market Share Analysis
Chapter 3 Rare Disease Genetic Testing Market Vavriables, Trends, & Scope
3.1 Market Segmentation
3.2 Rare Disease Genetic Testing Market: Industry Pyramid Analysis
3.2.1 Parent market outlook
3.2.2 Related/ancillary market outlook
3.3 Penetration and Growth Prospect Mapping for Technology, 2019
3.4 SWOT Analysis, by Factor (Political & Legal, Economic, And Technological)
3.5 Porter’s Five Forces Analysis
Chapter 4 Rare Disease Genetic Testing Market Industry Outlook
4.1 Market Dynamics
4.1.1 Market driver analysis
4.1.1.1 Expanding patient registry for rare disease
4.1.1.2 Declinig sequencing cost & Technological advancements in Disease diagnosis
4.1.1.3 Launch of programs & NEw product Development in Rare Disease diagnosis
4.1.2 Market restraint analysis
4.1.2.1 Absence of effective Diagnosis Framework
4.1.2.2 Technical challenges associated with genetic tests & data management
4.1.3 Market Opportunity Analysis
4.1.3.1 Government & regulatory support for rare disease diagnosis
4.1.4 Market Challenge Analysis
4.1.4.1 Limited awareness pertaning to the rare disease conditions
4.2 Regulatory Framework
4.2.1 U.S.
4.2.2 Europe
4.2.3 China
4.2.4 Japan
4.3 Major Deals And Strategic Alliances Analysis
4.3.1 New product launch
4.3.2 Mergers and acquisitions
4.3.3 Partnerships
4.4 Rare Disease Genetic Testing Market: Company Market Share Analysis
Chapter 5 Rare Disease Genetic Testing Market: Disease Type Movement Analysis
5.1 Rare Disease Genetic Testing Market: Disease Type Movement Analysis
5.2 Neurologic Diseases
5.2.1 Global genetic testing market for rare neurology diseases, 2016 - 2027 (USD Million)
5.3 Immunologic Disorders
5.3.1 Global genetic testing market for rare immunologic disorders, 2016 - 2027 (USD Million)
5.4 Hematology Diseases
5.4.1 Global genetic testing market for rare hematology diseases, 2016 - 2027 (USD Million)
5.5 Endocrine & Metabolism Diseases
5.5.1 Global genetic testing market for rare endocrine & metabolism diseases, 2016 - 2027 (USD Million)
5.6 Cancer
5.6.1 Global genetic testing market for rare cancer forms, 2016 - 2027 (USD Million)
5.7 Musculoskeletal Disorders
5.7.1 Global genetic testing market for rare musculoskeletal disorders, 2016 - 2027 (USD Million)
5.8 Cardiovascular Disorders (CVD)
5.8.1 Global genetic testing market for rare cardiovascular disorders, 2016 - 2027 (USD Million)
5.9 Dermatology Diseases
5.9.1 Global genetic testing market for rare dermatology diseases, 2016 - 2027 (USD Million)
5.10 Other Rare Diseases
5.10.1 Global genetic testing market for other rare diseases, 2016 - 2027 (USD Million)
Chapter 6 Rare Disease Genetic Testing Market: Technology Movement Analysis
6.1 Rare Disease Genetic Testing Market: Technology Movement Analysis
6.2 Next Generation Sequencing (NGS)
6.2.1 Global NGS - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
6.2.2 Whole Exome Sequencing (WES)
6.2.2.1 Global WES - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
6.2.3 Whole Genome Sequencing (WGS)
6.2.3.1 Global WGS - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
6.3 Array Technology
6.3.1 Global array technology - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
6.4 PCR - based Testing
6.4.1 Global PCR - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
6.5 FISH
6.5.1 Global FISH - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
6.6 Sanger Sequencing
6.6.1 Global Sanger Sequencing - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
6.7 Karyotyping
6.7.1 Global karyotyping - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
Chapter 7 Rare Disease Genetic Testing Market: Speciality Business Analysis
7.1 Molecular Genetic Tests
7.1.1 Global molecular genetic tests market for rare diseases, 2016 - 2027 (USD Million)
7.2 Chromosomal Genetic Tests
7.2.1 Global chromosomal genetic tests market for rare diseases, 2016 - 2027 (USD Million)
7.3 Biochemical Genetic Tests
7.3.1 Global biochemical genetic tests market for rare diseases, 2016 - 2027 (USD Million)
Chapter 8 Rare Disease Genetic Testing Market: End - Use Business Analysis
8.1 Research Laboratories & CROs
8.1.1 Global research laboratories & CROs - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
8.2 Diagnostic Laboratories
8.2.1 Global diagnostic laboratories - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
8.3 Hospitals & Clinics
8.3.1 Global hospitals & clinics - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
Chapter 9 Rare Disease Genetic Testing Market: Regional Movement Analysis
9.1 Rare Disease Genetic Testing Market: Regional Movement Analysis
9.2 North America
9.2.1 North America Rare Disease Genetic Testing Market estimates and forecast, 2016 - 2027 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.2.2.2 U.S. Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.2.2.3 U.S. Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.2.2.4 U.S. Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.2.3 Canada
9.2.3.1 Canada Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.2.3.2 Canada Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.2.3.3 Canada Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.2.3.4 Canada Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.3 Europe
9.3.1 Europe Rare Disease Genetic Testing Market estimates and forecast, 2016 - 2027 (USD Million)
9.3.2 Germany
9.3.2.1 Canada Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.3.2.2 Canada Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.3.2.3 Canada Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.3.2.4 Canada Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.3.3.2 U.K. Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.3.3.3 U.K. Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.3.3.4 U.K. Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.3.4 Spain
9.3.4.1 Spain Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.3.4.2 Spain Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.3.4.3 Spain Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.3.4.4 Spain Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.3.5 France
9.3.5.1 France Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.3.5.2 France Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.3.5.3 France Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.3.5.4 France Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.3.6 Italy
9.3.6.1 Italy Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.3.6.2 Italy Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.3.6.3 Italy Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.3.6.4 Italy Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.3.7 The Netherlands
9.3.7.1 The Netherlands Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.3.7.2 The Netherlands Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.3.7.3 The Netherlands Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.3.7.4 The Netherlands Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Rare Disease Genetic Testing Market estimates and forecast, 2016 - 2027 (USD Million)
9.4.2 Japan
9.4.2.1 Japan Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.4.2.2 Japan Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.4.2.3 Japan Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.4.2.4 Japan Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.4.3 China
9.4.3.1 China Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.4.3.2 China Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.4.3.3 China Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.4.3.4 China Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.4.4 India
9.4.4.1 India Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.4.4.2 India Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.4.4.3 India Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.4.4.4 india Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.4.5 South Korea
9.4.5.1 South Korea Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.4.5.2 South Korea Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.4.5.3 South Korea Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.4.5.4 South Korea Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.4.6 Singapore
9.4.6.1 Singapore Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.4.6.2 Singapore Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.4.6.3 Singapore Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.4.6.4 Singapore Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.4.7 Australia
9.4.7.1 Australia Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.4.7.2 Australia Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.4.7.3 Australia Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.4.7.4 Australia Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.4.8 South East Asia
9.4.8.1 South East Asia Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.4.8.2 South East Asia Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.4.8.3 South East Asia Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.4.8.4 South East Asia Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.5 Latin America
9.5.1 Latin America Rare Disease Genetic Testing Market estimates and forecast, 2016 - 2027 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.5.2.2 Brazil Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.5.2.3 Brazil Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.5.2.4 Brazil Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
9.6 Middle East and Africa
9.6.1 MEA Rare Disease Genetic Testing Market estimates and forecast, 2016 - 2027 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
9.6.2.2 South Africa Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
9.6.2.3 South Africa Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
9.6.2.4 South Africa Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
Chapter 10 Company Profile
10.1 Company Profiles
10.1.1 CENTOGENE N.V.
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 Invitae Corporation
10.1.2.1 Company overview
10.1.2.2 Financial Performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 3billion, Inc.
10.1.3.1 Company overview
10.1.3.2 Product benchmarking
10.1.3.3 Strategic initiatives
10.1.4 ARUP Laboratories
10.1.4.1 Company overview
10.1.4.2 Product benchmarking
10.1.4.3 Strategic initiatives
10.1.5 Eurofins Scientific
10.1.5.1 Company overview
10.1.5.2 EUROFINS Genoma Group Srl a socio unico
10.1.5.3 Financial Performance
10.1.5.4 Product benchmarking
10.1.5.5 Strategic initiatives
10.1.6 Strand Life Sciences
10.1.6.1 Company overview
10.1.6.2 Product benchmarking
10.1.6.3 Strategic initiatives
10.1.7 Quest Diagnostics Incorporated
10.1.7.1 Company overview
10.1.7.2 Blueprint Genetics Oy
10.1.7.3 Financial Performance
10.1.7.4 Product benchmarking
10.1.7.5 Strategic initiatives
10.1.8 PerkinElmer Genomics
10.1.8.1 Company overview
10.1.8.2 Financial Performance
10.1.8.3 Product benchmarking
10.1.9 Ambry Genetics
10.1.9.1 Company overview
10.1.9.2 Product benchmarking
10.1.9.3 Strategic initiatives
10.1.10 Macrogen, Inc.
10.1.10.1 Company overview
10.1.10.2 Product benchmarking
10.1.10.3 Strategic initiatives
10.1.11 Baylor Genetics
10.1.11.1 Company overview
10.1.11.2 Product benchmarking
10.1.11.3 Strategic initiatives
10.1.12 Color Genomics, Inc.
10.1.12.1 Company overview
10.1.12.2 Financial performance
10.1.12.3 Product benchmarking
10.1.12.4 Strategic initiatives
10.1.13 HEALTH NETWORK LABORATORIES
10.1.13.1 Company overview
10.1.13.2 Connective Tissue Gene Tests
10.1.13.2.1 Company overview
10.1.13.3 Product benchmarking
10.1.13.4 Strategic initiatives
10.1.14 PreventionGenetics
10.1.14.1 Company overview
10.1.14.2 Product benchmarking
10.1.14.3 Strategic initiatives
10.1.15 Progenity, Inc.
10.1.15.1 Company overview
10.1.15.2 Product benchmarking
10.1.16 CooperSurgical, Inc.
10.1.16.1 Company overview
10.1.16.2 Genesis Genetics
10.1.16.2.1 Company overview
10.1.16.3 Financial performance
10.1.16.4 Product benchmarking
10.1.16.5 Strategic initiatives
10.1.17 Fulgent Genetics Inc,
10.1.17.1 Company overview
10.1.17.2 Financial Performance
10.1.17.3 Product benchmarking
10.1.17.4 Strategic initiatives
10.1.18 Myriad Genetics, Inc.
10.1.18.1 Company overview
10.1.18.2 Counsyl, Inc.
10.1.18.2.1 Company overview
10.1.18.3 Financial Performance
10.1.18.4 Product benchmarking
10.1.18.5 Strategic initiatives
10.1.19 Laboratory Corporation of America Holdings
10.1.19.1 Company overview
10.1.19.2 Sequenom
10.1.19.2.1 Company overview
10.1.19.3 Financial Performance
10.1.19.3.1 Financial performance (Sequenom)
10.1.19.4 Product benchmarking
10.1.19.5 Strategic initiatives
10.1.20 OPKO Health, Inc.
10.1.20.1 Company overview
10.1.20.2 Bio - Reference Laboratories
10.1.20.2.1 Company overview
10.1.20.2.2 GeneDx
10.1.20.2.2.1 Company overview
10.1.20.2 Financial Performance
10.1.20.3 Product benchmarking
10.1.20.4 Strategic initiatives
List of Tables
Table 1 Inheritance pattern of rare diseases
Table 2 Distribution of registries by EU countries
Table 3 Rare disease policy and regulatory frameworks in EU, updated as of 2017
Table 4 North America rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 5 North America rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 6 North America NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 7 North America rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 8 North America rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 9 U.S. rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 10 U.S. rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 11 U.S. NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 12 U.S. rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 13 U.S. rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 14 Canada rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 15 Canada rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 16 Canada NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 17 Canada rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 18 Canada rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 19 Europe rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 20 Europe rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 21 Europe NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 22 Europe rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 23 Europe rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 24 Germany rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 25 Germany rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 26 Germany NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 27 Germany rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 28 Germany rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 29 U.K. rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 30 U.K. rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 31 U.K. NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 32 U.K. rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 33 U.K. rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 34 Spain rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 35 Spain rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 36 Spain NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 37 Spain rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 38 Spain rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 39 France rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 40 France rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 41 France NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 42 France rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 43 France rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 44 Italy rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 45 Italy rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 46 Italy NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 47 Italy rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 48 Italy rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 49 Netherlands rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 50 Netherlands rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 51 Netherlands NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 52 Netherlands rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 53 Netherlands rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 54 Asia Pacific rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 55 Asia Pacific rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 56 Asia Pacific NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 57 Asia Pacific rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 58 Asia Pacific rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 59 Japan rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 60 Japan rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 61 Japan NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 62 Japan rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 63 Japan rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 64 China rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 65 China rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 66 China NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 67 China rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 68 China rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 69 India rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 70 India rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 71 India NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 72 India rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 73 India rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 74 South Korea rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 75 South Korea rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 76 South Korea NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 77 South Korea rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 78 South Korea rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 79 Singapore rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 80 Singapore rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 81 Singapore NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 82 Singapore rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 83 Singapore rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 84 Australia rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 85 Australia rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 86 Australia NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 87 Australia rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 88 Australia rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 89 South East Asia rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 90 South East Asia rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 91 South East Asia NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 92 South East Asia rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 93 South East Asia rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 94 Latin America rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 95 Latin America rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 96 Latin America NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 97 Latin America rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 98 Latin America rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
Table 99 Brazil rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
Table 100 Brazil rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 101 Brazil NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
Table 102 Brazil rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
Table 1

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook